Location: Cambridge,MA, USA
COMPANY OVERVIEW
AIRNA is a biotechnology company with a mission to transform lives, one RNA edit at a time.
AIRNA is pioneering the discovery and development of RNA editing therapeutics to realize the therapeutic potential of base editing for patients with rare and common diseases. RNA editing modality is poised to lead the next generation of RNA therapeutics by bringing the precision of gene editing technology with a potent and safe medicine that can be conveniently re-dosed and manufactured. Our RESTORE+™ platform is based on groundbreaking research by academic co-founders Thorsten Stafforst (University of Tübingen) and Jin Billy Li (Stanford University), who were the first to elucidate a therapeutic approach for precise editing of RNA.
AIRNA has received $90 million in Series A financing from world class venture capital firms, including Forbion and Arch Venture Partners, and is headquartered in Cambridge, MA with research operations in Tübingen, Germany.
JOB DESCRIPTION:
AIRNA Bio is looking for a highly motivated and passionate Senior Scientist to be part of an outstanding team, supporting the discovery and optimization of the next generation of RNA editing oligonucleotide therapeutics. The qualified candidate should be well versed in and have demonstrated experience in CNS and/or Cardiometabolic diseases. This is a lab-based role and the successful candidate is expected to identify and develop disease specific animal models, optimize and execute relevant cell models and develop assays relevant for PK/PD and translational studies to advance multiple drug discovery programs to IND. Furthermore, we are looking for someone who shows high curiosity and engagement and is expected to independently design and conduct experiments. Finally, she/he will demonstrate clear and thoughtful communication, effectively collaborate with colleagues across different teams and can present scientific results to peers.
RESPONSIBILITIES
QUALIFICATIONS
LOCATION:
Cambridge, MA